Related Experiment Video
Updated: Sep 23, 2025

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Atypical Blepharospasm with Oromandibular Dystonia Associated with Cerebral Amyloid Angiopathy
Andrew R Carey1, Neil R Miller1
1Division of Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
A case of atypical blepharospasm with oromandibular dystonia is presented in a patient found to have cerebral amyloid angiopathy on magnetic resonance imaging and a shared mechanism is discussed.
Insights
This study presents a case of unusual blepharospasm and oromandibular dystonia. Cerebral amyloid angiopathy may share a common mechanism in these neurological conditions.
Area of Science:
- Neurology
- Neuroimaging
- Genetics
Background:
- Blepharospasm and oromandibular dystonia are focal involuntary movements.
- Cerebral amyloid angiopathy (CAA) is a cerebrovascular disease.
- The underlying mechanisms of these conditions are not fully understood.
Observation:
- A patient presented with atypical blepharospasm and oromandibular dystonia.
- Magnetic resonance imaging (MRI) revealed signs of cerebral amyloid angiopathy.
- This co-occurrence suggests a potential link between the conditions.
Findings:
- The case highlights an unusual presentation of blepharospasm and oromandibular dystonia.
- Cerebral amyloid angiopathy was identified as a co-existing condition.
- A shared underlying pathological mechanism is proposed.
Implications:
- This case may broaden the differential diagnosis for blepharospasm and oromandibular dystonia.
- Understanding shared mechanisms could lead to novel therapeutic targets.
- Further research into the link between CAA and dystonia is warranted.
More Related Videos
05:20A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
Published on: November 12, 2020
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview
Accessory Structures of the Eye
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...